Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
批准号:
10201425
负责人:
Matthias Johannes Schnell
金额:
$22.38万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-08-31
中文摘要
摘要
这是一个新的申请,提出了3名研究生和2名研究生的培训计划
针对微生物病原体和癌症的疫苗和免疫疗法方面的博士后研究员。
这项申请的基本原理是利用TJU在该地区的长期经验
在疫苗、治疗和癌症方面,需要这样一个独特的培训机会
费城,并有机会在基础和
病毒和肿瘤免疫的应用方面。TPVIIDC的一个重要特点是
21位导师的不同研究兴趣提供了一个机会,提供一个
综合基础科学、疫苗开发和
治疗学。鉴于还有其他癌症免疫学或疫苗方面的培训计划
对于传染病,从历史上看,这两种高度相关的疾病之间几乎没有相互作用
研究领域。我们强烈认为,我们的计划将通过以下方式帮助提供更好的培训
在不同但相关的癌症和传染病免疫学领域提供机会
疾病。而学生和研究员将在东道主那里度过他们的大部分时间
实验室,辅助机会将使参与的广泛互动成为可能
教职员工,通过共享研讨会、务虚会和课程设置来促进。
英文摘要
Summary
This is a new application that proposes a training program for 3 graduate students and 2
postdoctoral fellows in vaccines and immunotherapies against microbial pathogens and cancer.
The rationale for this application is to capitalize on the long-term experience of TJU in the area
of vaccines, therapeutics and cancer, the need for a such a unique training opportunity in
Philadelphia, and the opportunity to develop a “holistic” training experience in both basic and
applied aspects of viral and tumor immunity. An important characteristic of the TPVIIDC is that
the diversity of research interests of the 21 preceptors affords an opportunity to provide a
comprehensive training experience that integrates basic science, vaccine development and
therapeutics. Whereas there are other training programs in cancer immunology or vaccines
against infectious diseases there is historically little cross-talk between these highly related
research areas. We feel strongly that our program will help to provide better training by
providing opportunities in different but related areas of immunology of cancer and infectious
diseases. While the students and fellows will spend the majority of their time in their host
laboratory, ancillary opportunities will enable interaction with a wide range of the participating
faculty, facilitated by shared seminars, retreats and course offerings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Toward a protective Covid-19 vaccine utilizing an established vector platform
-
批准号:10170820
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
-
批准号:10078258
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
-
批准号:10311511
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
-
批准号:9905663
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
-
批准号:10465086
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2018
-
负责人:Matthias Johannes Schnell
-
依托单位:
Development of a single-dose rabies virus vaccine
-
批准号:10054163
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2016
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8790424
-
项目类别:
-
资助金额:$120.32万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:9205480
-
项目类别:
-
资助金额:$83.14万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8994257
-
项目类别:
-
资助金额:$109.09万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8496399
-
项目类别:
-
资助金额:$94.97万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8608481
-
项目类别:
-
资助金额:$94.51万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
A novel vaccine: botulinum neurotoxin subunit on a viral carrier.
-
批准号:8495212
-
项目类别:
-
资助金额:$85.85万
-
财政年份:2012
-
负责人:Matthias Johannes Schnell
-
依托单位:
A novel vaccine: botulinum neurotoxin subunit on a viral carrier.
-
批准号:8250086
-
项目类别:
-
资助金额:$81.76万
-
财政年份:2012
-
负责人:Matthias Johannes Schnell
-
依托单位:
RABIES VIRUS-BASED VECTORS AS AN HIV-1 VACCINE
-
批准号:8358036
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Matthias Johannes Schnell
-
依托单位:
RABIES VIRUS-BASED VECTORS AS AN HIV-1 VACCINE
-
批准号:8172927
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Matthias Johannes Schnell
-
依托单位:
Bat rabies virus in its natural host
-
批准号:7612601
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
RABIES VIRUS-BASED VECTORS AS AN HIV-1 VACCINE
-
批准号:7958584
-
项目类别:
-
资助金额:$5.81万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
Bat rabies virus in its natural host
-
批准号:7847579
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
Functional Analysis of NSV-based HIV vectors
-
批准号:7924009
-
项目类别:
-
资助金额:$131.42万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
Functional Analysis of NSV-based HIV vectors
-
批准号:7646605
-
项目类别:
-
资助金额:$136.21万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
海外基金